Abstract
BackgroundAdoptive cell therapies (ACT) utilizing neoantigen-specific T cells represents a promising approach to treat metastatic solid tumors.1–3 Multiple studies have demonstrated that antitumor tumor infiltrating lymphocytes (TIL) are highly enriched...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
